Persistent pain is a common reason for reduced quality of life after a spinal cord injury (SCI). Biomarkers of neuropathic pain may facilitate translational research and the understanding of underlying mechanisms. Research suggests that pain and affective distress are anatomically and functionally integrated in the anterior cingulate cortex and can modulate sensory and affective aspects of pain. We hypothesized that severe neuropathic pain with a significant psychosocial impact would be associated with metabolite concentrations (obtained by magnetic resonance spectroscopy) in the anterior cingulate cortex, indicating neuronal and/or glial dysfunction. Participants with SCI and severe, high-impact neuropathic pain (SCI-HPI; n = 16), SCI and moderate, low-impact neuropathic pain (SCI-LPI; n = 24), SCI without neuropathic pain (SCI-noNP; n = 14), and able-bodied, pain-free control subjects (A-B; n = 22) underwent a 3-T magnetic resonance imaging brain scan. Analyses revealed that the SCI-HPI group had significantly higher levels of myoinositol (Ins) (P < .000), creatine (P = .007), and choline (P = .014), and significantly lower levels of N-acetyl aspartate/Ins (P = .024) and glutamate-glutamine (Glx)/Ins (P = .003) ratios than the SCI-LPI group. The lower Glx/Ins ratio significantly discriminated between SCI-HPI and the A-B (P = .006) and SCI-noNP (P = .026) groups, displayed excellent test-retest reliability, and was significantly related to greater pain severity, interference, and affective distress. This suggests that the combination of lower glutamatergic metabolism and proliferation of glia and glial activation are underlying mechanisms contributing to the maintenance of severe neuropathic pain with significant psychosocial impact in chronic SCI. These findings indicate that the Glx/Ins ratio may be a useful biomarker for severe SCI-related neuropathic pain with significant psychosocial impact.
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Introduction
Persistent pain is one of the most common reasons for reduced quality of life after spinal cord injury (SCI) [8, 59] . The most rational approach for managing these refractory pain conditions is to identify the primary underlying mechanisms in each person and tailor treatment to these [5, 60] . Unfortunately, the identification of clinical subgroups, i.e., clinical phenotypes or other surrogate biomarkers of specific spinal cord, thalamic, and cortical mechanisms [24, 61] , has been difficult. There is a need to further examine potential biomarkers of neuropathic pain that may facilitate translational research and increase the understanding of underlying mechanisms.
The biopsychosocial model of pain suggests a dynamic interaction among biological, psychological, and social factors. Although biological mechanisms may initiate, maintain, and modulate pain, psychological factors influence the perception of pain and behavior in response to pain [50] . Therefore, an integrated assessment, including measures of pain severity and psychosocial impact, may be particularly relevant for complex persistent neuropathic
